Pittsburgh, PA, United States of America

Steven H Thorne

This inventor holds 2 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2013-2018.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Pittsburg, PA (US) (2013)
  • Pittsburgh, PA (US) (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Steven H. Thorne

Introduction

Steven H. Thorne is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of protein regulation through his innovative research. With a total of 2 patents, Thorne's work focuses on the development of synthetic small molecules that can regulate protein function in living cells.

Latest Patents

Thorne's latest patents include methods for regulating protein function in cells in vivo using synthetic small molecules. These methods and compositions allow for the rapid and reversible destabilization of specific proteins in vivo using cell-permeable, synthetic molecules. This innovative approach has the potential to advance the understanding of protein dynamics and their implications in various biological processes.

Career Highlights

Thorne is affiliated with Leland Stanford Junior University, where he continues to push the boundaries of research in protein regulation. His work has garnered attention for its potential applications in biotechnology and medicine.

Collaborations

Some of Thorne's notable coworkers include Thomas J. Wandless and Laura Anne Banaszynski. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Steven H. Thorne's innovative work in protein regulation exemplifies the impact of synthetic small molecules in biological research. His contributions continue to shape the future of biotechnology and medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…